insights_auto
Outlook: 79.0% bullish·0.0% bearish
Go to analysischevron_right
HAE:NYSE
Haemonetics Corp
$120.82
arrow_upward
+1.79%(+2.12) 1D
Oct 12, 12:17:56 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
$118.70
High
$121.60
Low
$118.36
Mkt. cap
5.50B
Avg. vol.
668.91K
Volume
313.62K
P/E ratio
58.93
52-wk high
$121.60
52-wk low
$48.55
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
Open
$118.70
High
$121.60
Low
$118.36
Mkt. cap
5.50B
Avg. vol.
668.91K
Volume
313.62K
P/E ratio
58.93
52-wk high
$121.60
52-wk low
$48.55
EPS
$2.05
Beta
0.61
Shares outstanding
45.50M
No. of employees
3K
News stories
From web sources and news partners
TradingView
·
19 minutes ago
S&P 500 surpasses 1,000 trading days without a new 52-week low
bloomingbit
·
26 minutes ago
U.S. Stocks Turn Mixed; Nasdaq Falls 0.20%
IndexBox
·
18 minutes ago
S&P 500 Record High Masks US Household Financial Strain
TradeWinds News
·
3 days ago
Nordic American Tankers top stock as shipping crushes S&P 500 in unprecedented quarter
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3.01K
Founded1971
HeadquartersBoston, Massachusetts, United States
SectorMedical device
Websitehaemonetics.com